Historical record - last NADAC publication: 1/22/2014

Product Information

PACLITAXEL 100 MG/16.7 ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $1.8891 per ML under NDC 63323076316. Its NADAC has been published 5 times since Jan 22, 2014.

PACLITAXEL 100 MG/16.7 ML VIAL

Paclitaxel
$1.8891per ML

Strength

6 mg/mL

NDC

63323076316

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INTRAVENOUS

Last Updated

1/22/2014

Active Ingredients

PACLITAXEL

Approval Type

Generic (ANDA)

FDA Application

ANDA077574

On Market Since

3/20/2009

Pharmacological Classes

Microtubule Inhibition
Microtubule Inhibitor

Price Statistics

The NADAC for PACLITAXEL 100 MG/16.7 ML VIAL has been published 5 times since Jan 22, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$1.8891 per ML
All-time high$1.8891 (Feb 19, 2014)
All-time low$1.8891 (Jan 22, 2014)
Median price$1.8891
Average price$1.8891
Largest weekly change0.0% (Jan 29, 2014)
Weeks tracked5
Tracking sinceJan 22, 2014

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

0.0%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 6%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of PACLITAXEL 100 MG/16.7 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for PACLITAXEL 100 MG/16.7 ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $1.8891 per ML (NDC 63323076316), effective Feb 19, 2014.

How has the price of PACLITAXEL 100 MG/16.7 ML VIAL changed over time?

Over the history we have for it, the NADAC for PACLITAXEL 100 MG/16.7 ML VIAL has held within roughly two percent of its current level. It has been tracked across 5 weekly CMS publications since Jan 22, 2014.

What are the highest and lowest recorded NADAC prices for PACLITAXEL 100 MG/16.7 ML VIAL?

Since Jan 22, 2014, the NADAC for PACLITAXEL 100 MG/16.7 ML VIAL has ranged from a low of $1.8891 (Jan 22, 2014) to a high of $1.8891 (Feb 19, 2014), with a median of $1.8891 per ML.

Are there cheaper alternatives to PACLITAXEL 100 MG/16.7 ML VIAL?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, PACLITAXEL 300 MG/50 ML VIAL, is $1.7700 per ML — about 6% below PACLITAXEL 100 MG/16.7 ML VIAL.

Who manufactures PACLITAXEL 100 MG/16.7 ML VIAL?

PACLITAXEL 100 MG/16.7 ML VIAL (NDC 63323076316) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.